The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Visually Isoattenuating Pancreatic Adenocarcinoma at Dynamic-Enhanced CT: Frequency, Clinical and Pathologic Characteristics, and Diagnosis at Imaging Examinations
Abstract
PURPOSE: To retrospectively determine the frequency, clinical and pathologic characteristics, and computed tomographic (CT) findings of visually isoattenuating pancreatic adenocarcinomas and to investigate the utility of magnetic resonance (MR) imaging and positron emission tomography (PET)/CT for detecting them. MATERIALS AND METHODS: Institutional review board approval was obtained. Patient informed consent was waived. Of 743 consecutive patients with pathologically proved pancreatic cancer, 644 patients (392 men, 252 women; mean age, 60 years ± 9.5 [standard deviation]) who had undergone both arterial and portal phase contrast material-enhanced CT were included. Visually isoattenuating pancreatic adenocarcinoma was defined as lesion isoattenuation in both scan phases. Serum levels of carbohydrate antigen 19-9, immunoglobulin G (IgG), and IgG fraction 4 (IgG4), survival after curative-intent surgery; and pathologic findings of visually isoattenuating pancreatic adenocarcinomas were analyzed. CT findings of visually isoattenuating pancreatic adenocarcinomas and the sensitivity of MR imaging and PET/CT for detecting them were determined. RESULTS: The frequency of visually isoattenuating pancreatic adenocarcinomas among pancreatic cancers was 5.4% (35 of 644). Serum levels of carbohydrate antigen 19-9, IgG, and IgG4 were elevated in 51.5% (17 of 33), 8.3% (one of 12), and 8.3% (one of 12) of patients, respectively. Visually isoattenuating pancreatic adenocarcinoma, compared with usual pancreatic adenocarcinoma, was independently associated with a better survival after curative-intent surgery: Adjusted hazard ratio was 0.430 (P = .006). Thirty surgically resected visually isoattenuating pancreatic adenocarcinomas were 1.5-4 cm (median, 3 cm). Their pathologic findings differed from those of usual pancreatic adenocarcinomas: lower tumor cellularity, more frequent intratumoral acinar tissue and islet cells, and less prominent tumor necrosis. Visually isoattenuating pancreatic adenocarcinomas showed various abnormalities at CT, which may suggest an isoattenuating mass or nodule. Sensitivities of MR imaging and PET/CT were 79.2% (19 of 24) and 73.7% (14 of 19), respectively. CONCLUSION: Visually isoattenuating pancreatic adenocarcinoma represents a small but meaningful subset of pancreatic cancer and has characteristic clinical and pathologic features. MR imaging and PET/CT may be useful as subsequent examinations when the patient is suspected of having the lesion at CT.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isoattenuating Pancreatic Adenocarcinoma at Multi–Detector Row CT: Secondary Signs
Prokesch, R. W., Chow, L. C., Beaulieu, C. F., Bammer, R., & Jeffrey, R. B. (2002) · Radiology · doi:10.1148/radiol.2243011284 · Cited by 337
Ishigami, K., Yoshimitsu, K., Irie, H., Tajima, T., Asayama, Y., Nishie, A., Hirakawa, M., Ushijima, Y., Okamoto, D., Nagata, S., et al. (2009) · European Journal of Radiology · doi:10.1016/j.ejrad.2007.09.012 · Cited by 79
Cited by
Early Detection of Pancreatic Cancer: Opportunities and Challenges
Singhi, A. D., Koay, E. J., Chari, S. T., & Maitra, A. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.01.259 · Cited by 841
Al-Hawary, M. M., Francis, I. R., Chari, S. T., Fishman, E. K., Hough, D. M., Lu, D. S., Macari, M., Megibow, A. J., Miller, F. H., Mortele, K. J., et al. (2014) · Radiology · doi:10.1148/radiol.13131184 · Cited by 491
Diagnosis and Detection of Pancreatic Cancer
Chu, L. C., Goggins, M. G., & Fishman, E. K. (2017) · The Cancer Journal · doi:10.1097/ppo.0000000000000290 · Cited by 296
Al-Hawary, M. M., Francis, I. R., Chari, S. T., Fishman, E. K., Hough, D. M., Lu, D. S., Macari, M., Megibow, A. J., Miller, F. H., Mortele, K. J., et al. (2014) · Gastroenterology · doi:10.1053/j.gastro.2013.11.004 · Cited by 285
Imaging diagnosis and staging of pancreatic ductal adenocarcinoma: a comprehensive review
Elbanna, K. Y., Jang, H.-J., & Kim, T. K. (2020) · Insights into Imaging · doi:10.1186/s13244-020-00861-y · Cited by 162
Metadata
- Authors
- Kim, J. H., Park, S. H., Yu, E. S., Kim, M.-H., Kim, J., Byun, J. H., Lee, S. S., Hwang, H. J., Hwang, J.-Y., Lee, S. S., & Lee, M.-G.
- Venue
- Radiology
- Published
- 2010-10
- Volume
- 257
- Issue
- 1
- Pages
- 87-96
- ISSN
- 0033-8419 (ISSN-L)
- 1527-1315
- OpenAlex
- W2141681933
- Cited by
- 249
- References
- 2
- FWCI
- 3.56
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Visually Isoattenuating Pancreatic Adenocarcinoma at Dynamic-Enhanced CT: Frequency, Clinical and Pathologic Characteristics, and Diagnosis at Imaging Examinations. https://app.cochat.ai/papers/10.1148/radiol.10100015
- The paper
- Kim, J. H., Park, S. H., Yu, E. S., Kim, M.-H., Kim, J., Byun, J. H., Lee, S. S., Hwang, H. J., Hwang, J.-Y., Lee, S. S., & Lee, M.-G. (2010). Visually Isoattenuating Pancreatic Adenocarcinoma at Dynamic-Enhanced CT: Frequency, Clinical and Pathologic Characteristics, and Diagnosis at Imaging Examinations. Radiology. https://doi.org/10.1148/radiol.10100015
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.